Stability study support of r-VK4-116
Ended Awarded Last action
- Contract number
- 75N91025F00023
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $98,473
Award facts
- Contract value 100% obligated
- $98,473.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $98,473.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for stability study support of the R-VK4-116 program, with a period of performance through June 25, 2026. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor that provides comprehensive biomedical research and facilities support services to federal agencies, including the NIH. The contract does not have a set-aside designation, indicating Leidos' competitive capabilities across a broad spectrum of scientific and technical services. This award is part of Leidos' broader portfolio of federal contract work, which includes significant contracts supporting medical research programs, IT infrastructure, and other critical government missions.
Quick answers
Who was awarded contract 75N91025F00023?
75N91025F00023 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2025.
How much is contract 75N91025F00023 worth?
The government has obligated $98,473 on 75N91025F00023.
Is contract 75N91025F00023 an order under another contract?
Yes. 75N91025F00023 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91025F00023 competed?
The extent of competition for 75N91025F00023 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award